General Atlantic Acquires Ujala Cygnus Hospital Chain
The Indian healthcare sector is experiencing a surge in investment activity, with global players recognizing its immense potential. In a recent landmark deal valued at approximately ₹1600 crore (US$192.32 million), private equity giant General Atlantic (GA) announced the acquisition of a 70% stake in Ujala Cygnus Healthcare Services. This strategic move strengthens GA’s presence in […]
Wipro-GE Healthcare Invests Rs 8,000 Cr: Make in India
Wipro-GE Healthcare, a prominent player in medical technology and digital solutions, announced a game-changing investment of Rs 8,000 crore ($1 billion) in India over the next five years. This substantial infusion of capital aims to propel the company’s “Make in India for the World” initiative forward, with a multi-pronged approach: Aligning with National Goals and […]
Axis Bank Funds ₹100 Cr for National Cancer Grid
In a significant boost to India’s fight against cancer, Axis Bank, a leading private sector bank, has announced a ₹100 crore contribution to the National Cancer Grid (NCG) spread over a five-year partnership. This strategic collaboration aims to revolutionize cancer care in India by focusing on three key areas: improved access, research advancements, and digital […]
Pharma Tech Benefits Now Reach Non-MSMEs
The Indian pharmaceutical industry is undergoing a major transformation as the government has revamped the Pharmaceuticals Technology Upgradation Assistance Scheme (PTUAS) to support drug companies in upgrading their facilities to produce medicines conforming to global standards. The scheme now extends beyond MSMEs to pharmaceutical manufacturing units with a turnover of less than Rs 500 crore […]
Karnataka Bans Artificial Colors in Gobi Manchurian
The Karnataka government has taken a strict action against the use of artificial colors in Gobi Manchurian, a popular Indo-Chinese dish, and cotton candy, a fluffy confectionery. The state health department has issued an order banning the use of coloring agents like Rhodamine-B, which are considered harmful and unsafe for human consumption. Why the ban? […]
First Govt Homeopathy College in Kathua, North India
North India’s first government homoeopathic college, centrally funded at a cost of Rs 80 crore, will be established in Jasrota area of Kathua district in Jammu and Kashmir, Union Minister of State Dr Jitendra Singh said on Sunday. The institution will provide cost-effective and integrated healthcare to the people of the region and will also […]
Government Panel Reviews Nutraceuticals’ CDSCO Inclusion
To address the regulatory challenges and consumer safety issues in nutraceuticals, the government has formed a high-level committee under the chairmanship of Secretary, Ministry of Health to review the regulatory challenges in nutraceuticals and drugs and examine the possibility of bringing nutraceuticals under CDSCO. The committee has as its members Secretary, Ministry of Ayush, Secretary, […]
Sukoon Health Offers Cashless Insurance for Mental Care
Sukoon Health, a chain of mental health hospitals, has launched a cashless insurance scheme for patients seeking psychiatric inpatient care. The scheme covers a wide range of mental health conditions and aims to make mental healthcare more accessible and affordable. Sukoon Health has collaborated with five private insurance companies to provide this initiative. The need […]
CDSCO New Sampling Guidelines for Drug and Cosmetic Quality
The Central Drugs Standard Control Organisation (CDSCO), the apex drug regulator in India, has issued new guidelines for effective surveillance for quality and efficacy of drugs and cosmetics available in the market by adopting a uniform drug sampling methodology. The guidelines, notified on February 9, 2024, aim to cover a vast variety of drugs, cosmetics […]
Dr. Reddy’s Aims to Acquire Novartis India
Dr. Reddy’s Laboratories, one of India’s leading pharma companies, is reportedly interested in acquiring a majority stake in Novartis India, the listed subsidiary of Swiss multinational Novartis AG. This comes after Novartis AG announced a strategic review of its 70.68% shareholding in Novartis India on February 16, 2024. Why Dr. Reddy’s wants Novartis India Dr. […]